NUCB2 and malignant colon neoplasm: Some studies have demonstrated that Nesfatin-1/Nucleobindin-2 can suppress the expression of E-cadherin and increase the expression of N-cadherin and Vimentin, thereby inducing migration, invasion, and EMT of colon cancer cells (142) (Table 1).